Open AccessPrognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases
Author(s) -
Yujiro Nishioka,
Jin Moriyama,
Shuichiro Matoba,
Hiroya Kuroyanagi,
Masaji Hashimoto,
Junichi Shindoh
Publication year - 2017
Publication title -
digestive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 69
eISSN - 1421-9983
pISSN - 0253-4886
DOI - 10.1159/000478791
Subject(s) - medicine , oxaliplatin , colorectal cancer , adjuvant , oncology , regimen , chemotherapy , gastroenterology , adjuvant chemotherapy , adverse effect , tegafur , cancer , breast cancer
Although the usefulness of adjuvant chemotherapy has been established in the treatment for stages II/III colorectal cancer, its prognostic advantage for colorectal liver metastases (CLM) remains controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom